Association of brain derived neurotrophic factor (BDNF) with inflammation in psoriasis

Authors

DOI:

https://doi.org/10.3126/ajms.v11i6.30389

Keywords:

Psoriasis, Brain derived neutrophic factor, Apremilast

Abstract

Background: Psoriasis is a common immune mediated chronic inflammatory disorder characterized by involvement of skin and other organ systems. Brain derived neurotrophic factor (BDNF) which has various roles in the nervous system, is also involved in cutaneous sensory innervation. Apremilast is a relatively new drug indicated for moderate-to-severe plaque psoriasis and psoriatic arthritis.

Aims and Objective: The present study aimed to explore the BDNF levels in moderate to severe plaque psoriasis and analyse the variation in the levels, if any, in response to apremilast therapy.

Materials and Methods: Blood samples from patients of psoriasis (n=24), of either sex and age ≥18 years suitable to be prescribed apremilast as standard treatment, were taken on initial and subsequent follow up visit after two months of therapy. Sample from matched controls were also evaluated. Enzyme-linked immunosorbent assay (ELISA) kit (QUAYEE-BIO) and microplate reader (at 450 nm) were used to determine BDNF values. Sample concentrations in each plate were calculated from standard curves and dilution factors.

Results: The BDNF values in healthy controls had a mean of 25.14 ± 14.21 ng/mL. The baseline values in the patients had a mean of 72.49± 9.05 ng/mL. The values in the patients after apremilast therapy had a mean of 63.60± 9.53 ng/mL.

Conclusion: BDNF levels are significantly increased in patients with moderate to severe plaque psoriasis. Apremilast therapy significantly reduced the raised BDNF levels in such patients, though the reduced level was still significantly higher than the levels in normal healthy controls. Rather than being linked to any neurobehavioral component, the BDNF levels predominantly appear to be linked to the underlying inflammation in psoriasis.

Downloads

Download data is not yet available.
Abstract
336
PDF
294
Cover 11(6)

Downloads

Published

2020-11-01

How to Cite

Moqaddasi, H., Dubey, A. K., Goel, S., Dubey  , S., & Maddali, G. K. (2020). Association of brain derived neurotrophic factor (BDNF) with inflammation in psoriasis. Asian Journal of Medical Sciences, 11(6), 72–76. https://doi.org/10.3126/ajms.v11i6.30389

Issue

Vol. 11 No. 6 (2020)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).